Laparoscopic Groin Hernia Repair by a 3D ENDOLAP Visible Mesh With or Without LiquiBand Fix 8 Mesh Fixation
Launched by ALGEMEEN ZIEKENHUIS MARIA MIDDELARES · May 20, 2016
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to repair groin hernias using a special type of mesh that can be seen on MRI scans. The goal is to see how well this mesh works when treated with either a new non-penetrating glue or without any glue at all. Researchers will include 100 adult patients who have a specific type of hernia called an inguinal hernia and are planned for a laparoscopic repair, which is a minimally invasive surgery. Eligible participants must be between 18 and 80 years old and should not have any complicated hernias or other medical conditions that would prevent them from participating.
If you decide to take part in this trial, you will have the surgery performed by experienced surgeons, and then you will have follow-up MRI scans at one and twelve months after the procedure to check on the mesh. This study is currently recruiting participants, and it aims to ensure the safety and effectiveness of this new mesh technique in helping individuals recover from hernias. Your involvement could help improve hernia repair methods for future patients!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult patients presenting with primary unilateral inguinal hernia
- • patients planed for a laparoscopic repair
- Exclusion Criteria:
- • Age below 18 years
- • recurrent or incarcerated hernias
- • open hernia repair and bilateral hernias
- • concomitant repair of another kind of abdominal hernia
- • combined surgical procedures
- • no informed consent
- • pregnant women
- • ASA score 4 or more
- • contra-indications for MRI scans.
About Algemeen Ziekenhuis Maria Middelares
Algemeen Ziekenhuis Maria Middelares is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Ghent, Belgium, the hospital is committed to adhering to the highest ethical and scientific standards in its research endeavors. With a multidisciplinary team of experienced healthcare professionals, the hospital focuses on a wide range of therapeutic areas, aiming to enhance treatment outcomes and patient quality of life. Its collaborative approach fosters partnerships with academic institutions and industry leaders, positioning Algemeen Ziekenhuis Maria Middelares as a pivotal contributor to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, , Belgium
Patients applied
Trial Officials
Filip Muysoms, MD, PhD
Principal Investigator
Algemeen Ziekenhuis Maria Middelares
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials